Tech Company Financing Transactions
Aspyrian Therapeutics Funding Round
Aspyrian Therapeutics, based in San Diego, raised $15.2 million from private investors.
Transaction Overview
Company Name
Announced On
10/6/2016
Transaction Type
Venture Equity
Amount
$15,199,998
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 8 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
11080 Roselle St.
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Developing the next generation of targeted therapies for oncology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Medical Officer
Merrill Biel
President
Miguel Garcia-Guzman
VP - Finance
Agatha Martindale
Browse more venture capital transactions:
Prev: 10/6/2016: Promentis Pharmaceuticals venture capital transaction
Next: 10/6/2016: Secure Medication Systems venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs